Cell Signaling and Receptors: Key Concepts for Exam

Signal = physical or molecular cue that needs to be interpreted by a cell; transduction = converting a signal into a form the cell can understand.
Transducers convert signals like hormones or neurotransmitters into cellular responses via receptors.
Radio analogy: a radio receives frequencies we cannot hear and transduces them into audible signals.
Key terms:
- Ligand: signal molecule that binds to a receptor.
- Receptor: protein that binds a ligand and initiates a signal transduction cascade.
- Transduction: conversion of the signal into a cellular response (often gene expression changes).
Frequencies and hearing (illustrative):
- Radio waves: $30 \,\text{Hz} \text{ to } 300 \,\text{MHz}$
- Human hearing range: $0.5 \,\text{kHz} \leq \text{Hz} \leq 20 \,\text{kHz}$
- Dogs can hear higher frequencies than humans (dog whistles).
Signal types can be molecular or physical (sound, light).
Most signals are molecules that bind receptors to trigger transduction; receptors are proteins embedded in membranes or located inside cells.
Lipophilic vs lipophobic signals:
- Lipophilic (fat-loving) signals can cross the plasma membrane and bind intracellular receptors (cytoplasmic or nuclear).
- Lipophobic (fat-insoluble) signals bind to membrane-bound receptors on the cell surface.
Some ligands can bind to receptors located in different places, producing different effects (tissue-specific responses).

Receptors are proteins; many are embedded in the plasma membrane and attached to the cytoskeleton.
Signal molecules can be hormones, neurotransmitters, or other molecules (e.g., taste-associated ligands).
Lipophilic ligands traverse the plasma membrane to bind:
- Nuclear receptors (in the nucleus) where gene expression is turned on/off.
- Cytoplasmic receptors (in the cytoplasm) that may translocate to the nucleus.
Lipophobic ligands bind to surface receptors and trigger transduction from the cell exterior.
Some hormones show multiple receptor localizations (e.g., estrogen: receptor types on membrane, cytoplasm, and nucleus).
Thyroid hormone example (described in class): not lipophilic in this material, but can enter cells and engage cytoplasmic receptors influencing gene expression.
Mechanism idea: receptors translate signals into cellular actions; different receptors produce different outcomes for the same ligand depending on tissue context.
Classic examples:
- Estrogen can act via nuclear, cytoplasmic, and membrane receptors.
- Hormones like steroids often bind intracellular receptors and influence gene expression.

Contact-dependent signaling:
- Cells directly exchange signals via membrane-bound receptors; essential in immune signaling.
Paracrine signaling:
- Signal molecule diffuses through extracellular space to nearby cells; not through blood.
- Regulates cells within the same organ.
Autocrine signaling:
- Cell responds to its own signal to regulate its own activity.
Endocrine signaling:
- Signal (hormone) released into blood, travels to distant targets with receptors.
Synaptic signaling:
- Neurons release neurotransmitters at synapses to adjacent cells with specific receptors; highly localized
Ligand-receptor specificity:
- Receptors are highly selective for their ligands; binding triggers specific intracellular responses.
Gap junctions (brief note):
- Direct cytoplasmic connections between neighboring cells; important in tissues like cardiac muscle (will be discussed later).

Surface (membrane) receptors:
- Ligands bind to receptors on the plasma membrane; exemplified by adrenergic receptors for epinephrine.
Intracellular receptors:
- Lipophilic ligands cross the membrane and bind cytoplasmic or nuclear receptors.
Nuclear receptors:
- Ligand-receptor complex acts as transcriptional regulators by binding DNA.
Cytoplasmic receptors:
- Ligand-receptor complexes may stay in cytoplasm or move to nucleus to affect gene expression.
Membrane receptors (extracellular signaling):
- Examples include adrenergic receptors; tissue-specific subtypes (e.g., beta1 in heart, beta2 in liver).
Ligand diversity and tissue context:
- The same ligand can have multiple effects because different receptors are expressed in different tissues.
Example recap: epinephrine (adrenaline) acts via different adrenergic receptor subtypes to:
- Increase heart rate (beta1 in heart)
- Increase respiration rate (beta2 in airway smooth muscle, etc.)
- Promote glycogen breakdown and glucose release in liver/muscle (beta receptors on liver)
Note on estrogen and receptors:
- Estrogen has multiple receptor localizations (membrane, cytoplasmic, nuclear) yielding diverse effects.
Practical implication:
- Receptor type and tissue location determine the physiological outcome of ligand binding.

Agonist:
- A molecule that binds a receptor and mimics the endogenous ligand's effect.
Antagonist:
- A molecule that binds a receptor but blocks the endogenous ligand’s effect.
Exogenous vs endogenous:
- Exogenous: drugs/compounds introduced from outside the body.
- Endogenous: produced within the body.
Mimetic terminology:
- A beta adrenergic receptor agonist is often called a mimetic.
Examples:
- Fluoxetine: a medication that reduces serotonin reuptake (acts on serotonin system but is not itself a receptor).
- Aspirin (salicylic acid) synthesized in 1899; analgesic effect; also inhibits enzymes COX-1 and COX-2 (isoforms) affecting prostaglandin synthesis.
Monoclonal antibodies (mAbs) in therapy:
- Herceptin: a monoclonal antibody that binds to HER2 receptor, blocking its signaling; used in HER2-positive cancers (e.g., certain breast cancers).
- Concept: antibodies can target receptors or ligands to modulate signaling.

Organismal diversity in receptor signaling:
- Some receptors can bind multiple ligands or have multiple isoforms across tissues.
Signaling exceptions and cross-talk:
- Receptors can have diverse downstream effects depending on tissue-specific coupling proteins.
COVID-19 context (receptors involved):
- SARS-CoV-2 binds to ACE2 receptors on host cells to gain entry; receptor presence explains tissue susceptibility and symptoms (e.g., loss of smell with neuronal involvement).
Summary idea:
- Molecules bind receptors with high specificity; the receptor type and tissue context define the cellular response and physiological outcome.

Transduction = converting signal to understandable cellular response.
Ligand = signal molecule; Receptor = binding partner.
Lipophilic ligands cross membranes; bind intracellular/nuclear receptors.
Lipophobic ligands bind surface receptors.
Communication types: contact-dependent, paracrine, autocrine, endocrine, synaptic.
Receptor specificity drives diverse tissue responses to the same ligand.
Pharmacology terms: agonist, antagonist, mimetic; endogenous vs exogenous ligands.
Therapeutics: monoclonal antibodies (e.g., Herceptin) block specific receptors.
Notable examples: aspirin targets COX isoforms; epinephrine acts on beta/alpha adrenergic receptors to coordinate systemic responses.
Viral entry example: viruses exploit receptors (e.g., ACE2) to enter cells.